Universal adoption of pathogen inactivation of platelet components: impact on platelet and red blood cell component use-Reference-Cited by-同舟云学术

Universal adoption of pathogen inactivation of platelet components: impact on platelet and red blood cell component use

Published:2009-07 Issue:7 Volume:49 Page:1412-1422
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:

Author:

Osselaer Jean Claude,Doyen Chantal,Defoin Laurence,Debry Cecile,Goffaux Maité,Messe Nathalie,Van Hooydonk Maryse,Bosly Andre,Lin Jin Sying,Lin Lily,Corash Laurence

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1537-2995.2009.02151.x/fullpdf

Reference18 articles.

1. Blood Manufacturing: Component Preparation, Storage, and Transportation

2. Bacterial detection of platelets: current problems and possible resolutions;Blajchman;Transfus Med Rev,2005

3. The threshold for prophylactic platelet transfusions in adults with acute myelogenous leukemia;Rebulla;N Engl J Med,1997

4. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions;TRAP Study Group;N Engl J Med,1997

5. Prophylactic platelet transfusions: which dose is the best dose? A review of the literature;Tinmouth;Transfus Med Rev,2003

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Platelet Pathogen Reduction Technology—Should We Stay or Should We Go…?;Journal of Clinical Medicine;2024-09-10

2. Longitudinal analysis of annual national hemovigilance data to assess pathogen reduced platelet transfusion trends during conversion to routine universal clinical use and 7‐day storage;Transfusion;2023-02-18

3. Health Economic Aspects of Platelet Concentrates: Comparing Cost and Reimbursement of Pathogen Inactivated and Conventional Platelet Concentrates in a German Comprehensive Cancer Center;Oncology Research and Treatment;2023

4. How do I implement pathogen‐reduced platelets?;Transfusion;2021-11-19

5. Efficacy of UVC-treated, pathogen-reduced platelets versus untreated platelets: a randomized controlled non-inferiority trial;Haematologica;2021-02-04